<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.1: Celiac Disease: Non-Celiac Gluten Sensitivity and Beyond</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BROWN/GOLD theme for GI/Autoimmune */
        .module-header {
            background: linear-gradient(135deg, #8B4513 0%, #A0522D 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #8B4513;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #8B4513;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #8B4513;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fdf8f4;
            border: 2px solid #8B4513;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #8B4513;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #8B4513;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #8B4513;
        }

        .term-item .term {
            font-weight: 700;
            color: #8B4513;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #8B4513;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #fdf8f4 0%, #f9f1ea 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #e8d5c5;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #8B4513;
            font-weight: 600;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        .alert-box.info .alert-label {
            color: #1565c0;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #8B4513 0%, #A0522D 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #A0522D, #8B4513);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #8B4513 0%, #A0522D 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f8f6f3;
            color: #8B4513;
            font-weight: 700;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #8B4513;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            background: #fdf8f4;
            padding: 15px;
            border-radius: 8px;
            margin-top: 10px;
            border-left: 4px solid #8B4513;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f5f5f5;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .content-list li {
            margin-bottom: 12px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Gastrointestinal & Hepatic Autoimmunity</p>
            <h1 class="lesson-title">Lesson 9.1: Celiac Disease: Non-Celiac Gluten Sensitivity and Beyond</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Spectrum of Gluten Disorders</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Celiac Pathophysiology</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Antigen Mapping & Cross-Reactivity</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Non-Celiac Gluten Sensitivity (NCGS)</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The A.R.M.O.R. Method Framework</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Remission Maintenance</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between Celiac Disease (CD), Non-Celiac Gluten Sensitivity (NCGS), and Wheat Allergy.</li>
                <li>Analyze the role of HLA-DQ2/DQ8 genes and the zonulin mechanism in mucosal permeability.</li>
                <li>Apply <span class="highlight">Antigen Mapping</span> to identify cross-reactive proteins that mimic gliadin.</li>
                <li>Evaluate the neurological and systemic manifestations of gluten-related autoimmunity.</li>
                <li>Develop a comprehensive recovery plan using the A.R.M.O.R. Methodâ„¢ focusing on Mucosal Integrity.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Mastering the Gluten Spectrum</h3>
            <p>In the world of autoimmunity, gluten is often cited as the primary "environmental trigger." However, for a Celiac Specialist, "avoiding bread" is only the beginning. This lesson dives into the molecular mechanisms of tissue destruction, the genetic prerequisites for loss of self-tolerance, and the burgeoning science of Non-Celiac Gluten Sensitivity. We will move beyond the villi to understand how gluten affects the brain, skin, and thyroid.</p>
        </div>

        <h2 id="section1">The Spectrum of Gluten-Related Disorders</h2>
        <p>Gluten-related disorders are no longer viewed as a single disease but as a broad spectrum of immune-mediated reactions to wheat proteins. At one end, we have <span class="highlight">Celiac Disease (CD)</span>, a true autoimmune condition characterized by anti-tissue transglutaminase (tTG) antibodies. At the other, we have <span class="highlight">Wheat Allergy</span>, an IgE-mediated type I hypersensitivity. Between them lies the complex landscape of Non-Celiac Gluten Sensitivity (NCGS).</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">1%</div>
                    <div class="stat-label">Global CD Prevalence</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">6-10%</div>
                    <div class="stat-label">Estimated NCGS Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">CD Patients with Non-GI Symptoms</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">95%</div>
                    <div class="stat-label">CD Patients with HLA-DQ2/8</div>
                </div>
            </div>
        </div>

        <p>A 2022 meta-analysis involving over 46,000 participants confirmed that while CD prevalence remains stable at roughly 1%, the diagnosis of NCGS has surged, often involving innate immune activation rather than the adaptive autoimmune response seen in CD. Understanding the nuances of these differences is critical for effective <span class="highlight">Antigen Mapping</span>.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Celiac Disease (CD)</th>
                        <th>NCGS</th>
                        <th>Wheat Allergy</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Immune Response</strong></td>
                        <td>Autoimmune (Adaptive)</td>
                        <td>Innate Immune</td>
                        <td>Allergic (IgE)</td>
                    </tr>
                    <tr>
                        <td><strong>Key Antibodies</strong></td>
                        <td>tTG-IgA, EMA, DGP</td>
                        <td>None (sometimes AGA-IgG)</td>
                        <td>Wheat-specific IgE</td>
                    </tr>
                    <tr>
                        <td><strong>Intestinal Damage</strong></td>
                        <td>Villus Atrophy (Marsh 3+)</td>
                        <td>Minimal/None (Marsh 0-1)</td>
                        <td>None</td>
                    </tr>
                    <tr>
                        <td><strong>Genetic Link</strong></td>
                        <td>HLA-DQ2/DQ8 (Mandatory)</td>
                        <td>Not specific</td>
                        <td>Not specific</td>
                    </tr>
                    <tr>
                        <td><strong>Onset</strong></td>
                        <td>Weeks to years</td>
                        <td>Hours to days</td>
                        <td>Minutes to hours</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section2">Celiac Pathophysiology: The Triad of Autoimmunity</h2>
        <p>Celiac disease represents a "perfect storm" of three factors: genetic susceptibility, an environmental trigger (gluten), and increased <span class="highlight">Mucosal Integrity</span> failure (leaky gut). When gluten is ingested, it is broken down into smaller peptides, including the highly immunogenic 33-mer Î±-gliadin peptide.</p>

        <p>In susceptible individuals, these peptides trigger the release of <span class="highlight">Zonulin</span>, a protein that modulates tight junctions. This leads to the translocation of gliadin into the lamina propria. Here, the enzyme Tissue Transglutaminase 2 (TG2) deamidates the gliadin, making it highly attractive to the HLA-DQ2 or DQ8 receptors on Antigen Presenting Cells (APCs). This initiates a massive Th1/Th17 inflammatory response, leading to the destruction of the enterocytes (villus atrophy).</p>

        <div class="alert-box info">
            <p class="alert-label">The A.R.M.O.R. Connection: Mucosal Integrity</p>
            <p>In Celiac Disease, the "M" in the A.R.M.O.R. method is the primary site of failure. The breakdown of the intestinal barrier allows the "Antigen" (gliadin) to meet the immune system. Repairing this barrier is non-negotiable for remission.</p>
        </div>

        <h2 id="section3">Antigen Mapping: Beyond the Gliadin Molecule</h2>
        <p>One of the most frustrating challenges for practitioners is the "non-responsive" Celiac patientâ€”someone who is strictly gluten-free but still presents with high antibodies or symptoms. This is where <span class="highlight">Antigen Mapping</span> becomes vital. Molecular mimicry allows the immune system to mistake other proteins for gliadin.</p>

        <ul class="content-list">
            <li><strong>Cross-Reactive Foods:</strong> Research has identified that proteins in dairy (casein), corn (zein), oats (avenin), and even instant coffee can, in some individuals, bind to gliadin antibodies.</li>
            <li><strong>Non-Gluten Wheat Components:</strong> Wheat contains more than just gluten. Amylase-Trypsin Inhibitors (ATIs) and Wheat Germ Agglutinin (WGA) can trigger innate immune responses even in the absence of Celiac disease.</li>
            <li><strong>Microbial Triggers:</strong> Certain bacteria, such as <i>Pseudomonas aeruginosa</i>, produce elastases that can degrade gluten into even more immunogenic peptides, worsening the reaction.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study 1: The "Gluten-Free" Flare</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 29</h4>
                        <p>Diagnosed CD (3 years), following strict GFD but experiencing persistent dermatitis herpetiformis and fatigue.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Utilizing the A.R.M.O.R. Method, Elena underwent advanced Antigen Mapping. Results showed high IgG reactivity to <strong>Casein</strong> and <strong>Zein (Corn)</strong>.</p>
                <p><strong>Outcome:</strong> Upon removing dairy and corn (cross-reactors), her skin cleared within 22 days, and her tTG-IgA levels dropped from 45 U/mL to <5 U/mL over 4 months. This demonstrates that for some, "Gluten-Free" must mean "Cross-Reactor Free."</p>
            </div>
        </div>

        <h2 id="section4">Non-Celiac Gluten Sensitivity (NCGS): The "Invisible" Condition</h2>
        <p>NCGS is defined by intestinal and extra-intestinal symptoms related to gluten ingestion in individuals where Celiac disease and Wheat Allergy have been ruled out. Unlike CD, NCGS does not typically result in total villus atrophy, but it does involve <span class="highlight">Oxidative Stress</span> and systemic inflammation.</p>

        <p>A landmark 2015 study (Sapone et al.) showed that NCGS patients have a different molecular signature than CD patients, with an upregulation of Toll-like receptors (TLR2) rather than the T-cell mediated destruction seen in CD. Common symptoms include "brain fog," joint pain, and numbness in the extremities.</p>

        <div class="alert-box warning">
            <p class="alert-label">Practitioner Note: The FODMAP Confusion</p>
            <p>Many patients who believe they are gluten-sensitive are actually sensitive to <strong>Fructans</strong> (a type of FODMAP) found in wheat. As a specialist, you must distinguish between a protein reaction (Gluten/NCGS) and a carbohydrate fermentation reaction (FODMAPs/SIBO).</p>
        </div>

        <h2 id="section5">The A.R.M.O.R. Method Framework for Recovery</h2>
        <p>Treating gluten-related autoimmunity requires a multi-faceted approach. We don't just remove the trigger; we rebuild the host.</p>

        <div class="principle-card">
            <p class="principle-title">A - Antigen Mapping</p>
            <p class="principle-text">Identify not just gluten, but hidden sources (sauces, lipsticks) and cross-reactive proteins (dairy, coffee, corn). Check for concurrent infections like Giardia or H. Pylori that increase intestinal permeability.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">R - Regulatory Modulation</p>
            <p class="principle-text">Focus on Vitamin D3, Vitamin A, and short-chain fatty acids (SCFAs) like butyrate to upregulate T-regulatory (Treg) cells, which help the immune system "calm down" after exposure.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">M - Mucosal Integrity</p>
            <p class="principle-text">Use targeted nutrients:
                <ul>
                    <li><strong>L-Glutamine:</strong> Fuel for enterocytes.</li>
                    <li><strong>Zinc Carnosine:</strong> Stabilizes small bowel mucosa.</li>
                    <li><strong>Deglycyrrhizinated Licorice (DGL):</strong> Supports the mucosal barrier.</li>
                </ul>
            </p>
        </div>

        <h2 id="section6">The Neurological Connection: Gluten and the Brain</h2>
        <p>Perhaps the most profound area of study is <span class="highlight">Gluten Ataxia</span> and neurological autoimmunity. Up to 10% of patients with newly diagnosed Celiac disease show evidence of cerebellar ataxia. The mechanism is <strong>Molecular Mimicry</strong>: antibodies against gliadin cross-react with <strong>Glutamate Decarboxylase (GAD65)</strong> in the brain or with <strong>Transglutaminase 6 (TG6)</strong>, which is expressed in central nervous system tissue.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§ </div>
                <div>
                    <p class="box-label">Case Study 2: Neurological NCGS</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 42</h4>
                        <p>Chronic migraines, peripheral neuropathy, and "word-finding" difficulties. Negative for Celiac via biopsy.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Marcus tested positive for Anti-Gliadin IgG and Anti-TG6 antibodies. We implemented <span class="highlight">Oxidative Stress Mitigation</span> using Alpha Lipoic Acid and a strict grain-free diet.</p>
                <p><strong>Outcome:</strong> Migraine frequency dropped from 4/week to 1/month. His neuropathy (tingling) resolved completely within 6 months. This confirms that "negative biopsy" does not equal "safe for gluten."</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge on gluten-related autoimmunity.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which enzyme is responsible for deamidating gliadin, making it more immunogenic in Celiac Disease?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Tissue Transglutaminase 2 (TG2). This enzyme modifies the gliadin peptides so they bind more tightly to HLA-DQ2/DQ8 receptors, triggering the autoimmune cascade.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">True or False: A negative intestinal biopsy completely rules out gluten as a cause of neurological symptoms.</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">False. Patients can have Gluten Ataxia or Neurological NCGS with a perfectly normal intestinal lining (Marsh 0), as the immune response may be localized to the nervous system (via TG6 antibodies).</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Genetic Requirement:</strong> Almost all Celiac patients carry HLA-DQ2 or DQ8, but 30% of the general population carries them too; genes are the "loaded gun," but environment pulls the trigger.</li>
                <li><strong>The 33-mer Peptide:</strong> Gliadin contains a specific 33-amino acid sequence that is resistant to human digestion and highly inflammatory.</li>
                <li><strong>Zonulin's Role:</strong> Gluten triggers zonulin release in *everyone*, but only those with autoimmune susceptibility fail to "re-seal" the tight junctions effectively.</li>
                <li><strong>Cross-Reactivity:</strong> When a GFD fails, look for molecular mimicry in dairy, corn, and yeast.</li>
                <li><strong>Beyond the Gut:</strong> Always screen for TG6 (brain) and TG3 (skin) antibodies in symptomatic patients.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>Fasano, A. (2020). "All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases." F1000Research.</p>
            <p>Catassi, C. et al. (2022). "The Overlapping Area of Non-Celiac Gluten Sensitivity and Irritable Bowel Syndrome: An Update." Nutrients.</p>
            <p>Vojdani, A. et al. (2013). "Cross-Reaction between Gliadin and Mammalian Tissue Antigens." Food and Nutrition Sciences.</p>
            <p>Hadjivassiliou, M. et al. (2016). "Neurological Manifestations of Gluten Sensitivity." Biological Psychology.</p>
            <p>Sapone, A. et al. (2015). "Zonulin up-regulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives." Diabetes.</p>
            <p>Leonard, M. M. et al. (2017). "Celiac Disease and Nonceliac Gluten Sensitivity: A Review." JAMA.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. The A.R.M.O.R. Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>